Author of the publication

Global trends in clinical trials of ivermectin for COVID-19—Part 2

, , , and . Japanese Journal of Antibiotics, 77 (1): 45--92 (March 2024)
DOI: 10.11553/antibiotics.77.1_45

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Global trends in clinical studies of ivermectin in COVID-19, , , and . Japanese Journal of Antibiotics, 74 (1): 44-95 (2021)Global trends in clinical studies of ivermectin in COVID-19.Global trends in clinical trials of ivermectin for COVID-19—Part 2, , , and . Japanese Journal of Antibiotics, 77 (1): 45--92 (March 2024)Ivermectin, ‘Wonder drug’ from Japan: the human use perspective, and . Proceedings of the Japan Academy, Series B, 87 (2): 13-28 (2011)Genome-minimized Streptomyces host for the heterologous expression of secondary metabolism., , , , and . Proceedings of the National Academy of Sciences of the United States of America, 107 (6): 2646--2651 (Feb 9, 2010)